A mouse model and pathogenesis study for CVA19 first isolated from hand, foot, and mouth disease

Emerg Microbes Infect. 2023 Dec;12(1):2177084. doi: 10.1080/22221751.2023.2177084.

Abstract

ABSTRACTCoxsackievirus A19 (CVA19) is a member of Enterovirus (EV) C group in the Picornaviridae family. Recently, we reported a case of CVA19-infected hand, foot, and mouth disease (HFMD) for the first time. However, the current body of knowledge on the CVA19 infection, particularly the pathogenesis of encephalomyelitis and diarrhoea is still very limited, due to the lack of suitable animal models. Here, we successfully established a CVA19 mouse model via oral route based on 7-day-old ICR mice. Our results found the virus strain could directly infect the neurons, astrocytes of brain, and motor neurons of spinal cord causing neurological complications, such as acute flaccid paralysis. Importantly, viruses isolated from the spinal cords of infected mice caused severe illness in suckling mice, fulfilling Koch's postulates to some extent. CVA19 infection led to diarrhoea with typical pathological features of shortened intestinal villi, increased number of secretory cells and apoptotic intestinal cells, and inflammatory cell infiltration. Much higher concentrations of serum cytokines and more peripheral blood inflammatory cells in CVA19-infected mice indicated a systematic inflammatory response induced by CVA19 infection. Finally, we found ribavirin and CVA19 VP1 monoclonal antibody could not prevent the disease progression, but higher concentrations of antisera and interferon alpha 2 (IFN-α2) could provide protective effects against CVA19. In conclusion, this study shows that a natural mouse-adapted CVA19 strain leads to diarrhoea and encephalomyelitis in a mouse model via oral infection, which provides a useful tool for studying CVA19 pathogenesis and evaluating the efficacy of vaccines and antivirals.

Keywords: Coxsackievirus A19; and mouth disease; diarrhoea; encephalomyelitis; foot; hand; oral infection.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Disease Models, Animal
  • Encephalomyelitis*
  • Enterovirus A, Human*
  • Hand, Foot and Mouth Disease*
  • Mice
  • Mice, Inbred ICR

Substances

  • Antiviral Agents

Grants and funding

This research was funded by the National Natural Science Foundation of China [grant number 82273695]; [grant number 82002147]; [grant number 82073618]; China Postdoctoral Science Foundation [grant number 2019M662543]; Key Scientific Research Project of Henan Institution of Higher Education [grant number 20A330004]; [grant number 21A310026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.